Insulina glargina
RxNorm 274783· ATC A10AE04· insulin glargine
KR · 한국Productos en Corea (22)
- 글라지아프리필드펜(인슐린글라진유전자재조합)(주)녹십자
- 글라지아프리필드펜(인슐린글라진유전자재조합)(주)녹십자
- 란투스주바이알(인슐린글라진유전자재조합)(주)사노피-아벤티스코리아
- 란투스주솔로스타(인슐린글라진유전자재조합)(주)사노피-아벤티스코리아
- 란투스주솔로스타(인슐린글라진유전자재조합)(주)사노피-아벤티스코리아
- 란투스주솔로스타(인슐린글라진유전자재조합)(주)사노피-아벤티스코리아
- 란투스주솔로스타(인슐린글라진유전자재조합)(주)사노피-아벤티스코리아
- 란투스주카트리지시스템(옵티클릭용)(인슐린글라진유전자재조합)(주)사노피-아벤티스코리아
- 투제오주솔로스타(인슐린글라진유전자재조합)(주)사노피-아벤티스코리아
- 투제오주솔로스타(인슐린글라진유전자재조합)(주)사노피-아벤티스코리아
- 솔리쿠아펜주(30-60)(주)사노피-아벤티스코리아
- 솔리쿠아펜주(30-60)(주)사노피-아벤티스코리아
- 솔리쿠아펜주(10-40)(주)사노피-아벤티스코리아
- 솔리쿠아펜주(10-40)(주)사노피-아벤티스코리아
- 베이사글라카트리지100단위/밀리리터(인슐린글라진,유전자재조합)한국릴리(유)
- 베이사글라카트리지100단위/밀리리터(인슐린글라진,유전자재조합)한국릴리(유)
- 베이사글라카트리지100단위/밀리리터(인슐린글라진,유전자재조합)한국릴리(유)
- 베이사글라퀵펜100단위/밀리리터(인슐린글라진유전자재조합)한국릴리(유)
- 베이사글라퀵펜100단위/밀리리터(인슐린글라진유전자재조합)한국릴리(유)
- 베이사글라퀵펜100단위/밀리리터(인슐린글라진유전자재조합)한국릴리(유)
- 베이사글라퀵펜100단위/밀리리터(인슐린글라진유전자재조합)한국릴리(유)
- 베이사글라퀵펜100단위/밀리리터(인슐린글라진유전자재조합)한국릴리(유)
U.S. drug label (openFDA)
BASAGLAR KwikPen — indications, dosage, warnings, adverse events →Química (PubChem)
- Fórmula molecular
- C267H404N72O78S6
- Peso molecular
- 6063 g/mol
- Nombre IUPAC
- (4S)-4-[[2-[[(1R,6R,12S,15S,18S,21S,24S,27S,30S,33S,36S,39S,42R,47R,50S,53S,56S,59S,62S,65S,68S,71S,74R,77S,80S,83S,88R)-88-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[(2-aminoacetyl)amino]-3-methylpentanoyl]amino]-3-methylbutanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]-6-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-3-methylbutanoyl]amino]-4-oxobutanoyl]amino]-5-oxopentanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-methylpentanoyl]amino]-53-(2-amino-2-oxoethyl)-62-(3-amino-3-oxopropyl)-77-[(2S)-butan-2-yl]-24,56-bis(2-carboxyethyl)-47-(carboxymethylcarbamoyl)-83-[(1R)-1-hydroxyethyl]-12,71,80-tris(hydroxymethyl)-33,50,65-tris[(4-hydroxyphenyl)methyl]-15-(1H-imidazol-4-ylmethyl)-27-methyl-18,30,36,59,68-pentakis(2-methylpropyl)-7,10,13,16,19,22,25,28,31,34,37,40,49,52,55,58,61,64,67,70,73,76,79,82,85,87-hexacosaoxo-21,39-di(propan-2-yl)-3,4,44,45,90,91-hexathia-8,11,14,17,20,23,26,29,32,35,38,41,48,51,54,57,60,63,66,69,72,75,78,81,84,86-hexacosazabicyclo[72.11.7]dononacontane-42-carbonyl]amino]acetyl]amino]-5-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[(2S)-2-[[(2S)-6-amino-1-[[(2S,3R)-1-[[(2S)-5-carbamimidamido-1-[[(1S)-4-carbamimidamido-1-carboxybutyl]amino]-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-hydroxy-1-oxobutan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-oxopentanoic acid
- InChIKey
- COCFEDIXXNGUNL-RFKWWTKHSA-N